1. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models. Issue 12 (12th June 2015) Authors: Gravina, Giovanni Luca; Mancini, Andrea; Muzi, Paola; Ventura, Luca; Biordi, Leda; Ricevuto, Enrico; Pompili, Simona; Mattei, Claudia; Di Cesare, Ernesto; Jannini, Emmanuele A.; Festuccia, Claudio Journal: Prostate Issue: Volume 75:Issue 12(2015) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗